KLYG — Kelyniam Global Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapFalling Star

Annual income statement for Kelyniam Global, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2008 December 31st	2009 December 31st	2010 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	10-K	ARS
Standards:	—	—	—	U USG	U USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.451	0.273	0.201	3.33	3.05
Cost of Revenue
Gross Profit	0.302	0.17	0.084	2.59	2.39
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	0.658	0.47	0.441	3.46	3.15
Operating Profit	-0.207	-0.197	-0.24	-0.135	-0.096
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.221	-0.215	-0.257	-1.14	-0.202
Provision for Income Taxes
Net Income After Taxes	-0.221	-0.215	-0.257	-0.92	-0.139
Net Income Before Extraordinary Items
Net Income	-0.221	-0.215	-0.257	-0.92	-0.139
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-0.221	-0.215	-0.257	-0.92	-0.139
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.011	-0.017	-0.02	-0.013	-0.003
Dividends per Share